Xylazine

ADVERTISEMENT

Identification

Molecular formula
C12H16N2O
CAS Number
7361-61-7
IUPAC Name
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol
Molecular Weight
220.27g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2300g/cm3
Synonyms
phentolamine
Interesting facts

Interesting Facts about 3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol

This complex organic compound is a fascinating example from the world of medicinal chemistry. Known for its diverse applications, it showcases the beauty of structure-activity relationships in drug design.

Key Highlights:

  • Pharmacological Potential: The imidazole moiety often contributes to biological activity, making compounds like this one important for drug development targeting various diseases.
  • Design Innovation: The unique fusion of a phenolic group with an imidazole contributes to its potential as a pharmacophore – a structural feature responsible for its therapeutic effects.
  • Structure Complexity: The presence of multiple functional groups allows for intricate interactions at the molecular level, enhancing its efficacy in biological systems.
  • Research Interest: Ongoing studies frequently explore its potential roles in treating conditions such as cancer, inflammation, and infectious diseases, showcasing its versatility.

As a scientist or chemistry student, it is invigorating to consider the implications of such compounds in pharmaceuticals. The interplay of chemistry and biology exemplifies how slight modifications in structure can lead to profound changes in function. “The magic of chemistry lies in the unseen connections”, one might say, reflecting on the intricate relationships within these molecules.

In conclusion, compounds like 3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol remind us of the vast frontier of organic chemistry and its impact on science and medicine. The continuous exploration of these structures holds the promise for the next generation of therapies.

ADVERTISEMENT